0001209191-23-037122.txt : 20230614
0001209191-23-037122.hdr.sgml : 20230614
20230614173540
ACCESSION NUMBER: 0001209191-23-037122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREY MICHAEL G
CENTRAL INDEX KEY: 0001240122
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 231015228
MAIL ADDRESS:
STREET 1: C/O SGX PHARMACEUTICALS, INC.
STREET 2: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-12
0
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001240122
GREY MICHAEL G
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050
FOSTER CITY
CA
94404
1
0
0
0
0
Stock Option (right to buy)
28.97
2023-06-12
4
A
0
17000
0.00
A
2033-06-11
Common Stock
17000
17000
D
The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting.
/s/ Judit Ryvkin, Attorney-in-Fact
2023-06-14